A Study Evaluating Long-Term Effect of Testosterone Undecanoate (TU) On Diabetic And Anthropometric Measures In Hypogonadal Men With Type-2 Diabetes Mellitus.

Trial Profile

A Study Evaluating Long-Term Effect of Testosterone Undecanoate (TU) On Diabetic And Anthropometric Measures In Hypogonadal Men With Type-2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2016 New trial record
    • 16 Sep 2016 Results assessing long-term effect of testosterone-undecanoate on diabetic and anthropometric measures, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top